Fabio S. Silveira - Publications

Intensive Blood-Pressure Control for the Prevention of Major Cardiovascular Events in Patients with Type 2 Diabetes: Rationale, Design and Baseline Characteristics of the OPTIMAL-DIABETES Randomized Trial.

Journal: American heart journal

Published: June 09, 2026

P2Y12 inhibitor monotherapy versus dual antiplatelet therapy after complex percutaneous coronary intervention in patients with acute coronary syndromes: a NEO-MINDSET trial substudy.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: May 27, 2026

Brazilian Guideline for the Evaluation and Diagnosis of Chest Pain in the Emergency Department - 2025.

Journal: Arquivos brasileiros de cardiologia

Published: December 11, 2025

Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes.

Journal: The New England journal of medicine

Published: September 01, 2025

Efficacy and Safety of a Novel Triple Single-Pill for Uncontrolled Hypertension: The OPTION TREAT Trial.

Journal: JACC. Advances

Published: August 06, 2025

Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER Trial.

Journal: JACC. Advances

Published: July 15, 2025

Disparities in access and three-year survival of patients with ST-elevation myocardial infarction treated in percutaneous coronary intervention-capable hospitals within the Brazilian public and private healthcare systems: The VICTIM extended registry.

Journal: Public health

Published: May 19, 2025

Effectiveness and Safety of Edoxaban in the Routine Clinical Care of Atrial Fibrillation Patients in Brazil: Prospective 1-Year Follow-Up Study - EdoBRA.

Journal: Arquivos brasileiros de cardiologia

Published: September 18, 2024

Multifaceted Strategy Based on Automated Text Messaging After a Recent Heart Failure Admission: The MESSAGE-HF Randomized Clinical Trial.

Journal: JAMA cardiology

Published: December 06, 2023

In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: A prespecified analysis of the VIP-ACS trial.

Journal: Vaccine

Published: September 26, 2023

P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: June 12, 2023

National Registry of Hypertension Control Evaluated by Office and Home Measurements: The LHAR National Registry.

Journal: Arquivos brasileiros de cardiologia

Published: November 27, 2022